Skip to content

Study · Not a test of the peptide alone · 1984

2 results

Comparison between bretylium and diphenylhydantoin interaction with mucosal sodium-channels.

Ilani A, Yachin S, Lichtstein D

Biochimica et biophysica acta1 Nov 1984Cited by 7 (Europe PMC)

PMID6091758 (opens in a new tab)DOI10.1016/0005-2736(84)90434-6 (opens in a new tab)PepBankPUB-06091758
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01LabNot a test of Oxytocin aloneEx vivo tissueMechanism

    In frog skin, the stimulatory effect of diphenylhydantoin was additive to the effect of oxytocin.

    In plain wordsIn lab tests on frog skin, diphenylhydantoin's stimulatory effect added to oxytocin's effect.

    Peptide
    Oxytocin
    Outcome
    Not applicableAdditivity of diphenylhydantoin with oxytocin
    Study

    frogn: not reported in source

    frog skin
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The diphenylhydantoin or the bretylium stimulatory effects are additive to the effects of oxytocin.
    1 context sentence
    Summary · context
    The antifibrillatory drug bretylium and the antiepileptic drug diphenylhydantoin cause an increase in the potential different and in the short-circuit current (SCC) across frog skin when added to the outer surface.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 02LabNot a test of Oxytocin aloneEx vivo tissueMechanism

    In frog skin, the stimulatory effect of bretylium was additive to the effect of oxytocin.

    In plain wordsIn lab tests on frog skin, bretylium's stimulatory effect added to oxytocin's effect.

    Peptide
    Oxytocin
    Outcome
    Not applicableAdditivity of bretylium with oxytocin
    Study

    frogn: not reported in source

    frog skin
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The diphenylhydantoin or the bretylium stimulatory effects are additive to the effects of oxytocin.
    1 context sentence
    Summary · context
    The antifibrillatory drug bretylium and the antiepileptic drug diphenylhydantoin cause an increase in the potential different and in the short-circuit current (SCC) across frog skin when added to the outer surface.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:54 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.